DK528279A - Fremgangsmaade til isolering af hepatitis b e antigen eller antistof - Google Patents

Fremgangsmaade til isolering af hepatitis b e antigen eller antistof

Info

Publication number
DK528279A
DK528279A DK528279A DK528279A DK528279A DK 528279 A DK528279 A DK 528279A DK 528279 A DK528279 A DK 528279A DK 528279 A DK528279 A DK 528279A DK 528279 A DK528279 A DK 528279A
Authority
DK
Denmark
Prior art keywords
hepatitis
antigen
antibody
insulating
procedure
Prior art date
Application number
DK528279A
Other languages
English (en)
Inventor
W J Mcaleer
E H Wasmuth
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK528279A publication Critical patent/DK528279A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK528279A 1978-12-13 1979-12-12 Fremgangsmaade til isolering af hepatitis b e antigen eller antistof DK528279A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/968,896 US4204989A (en) 1978-12-13 1978-12-13 Isolation of hepatitis B e antigen

Publications (1)

Publication Number Publication Date
DK528279A true DK528279A (da) 1980-06-14

Family

ID=25514908

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528279A DK528279A (da) 1978-12-13 1979-12-12 Fremgangsmaade til isolering af hepatitis b e antigen eller antistof

Country Status (8)

Country Link
US (1) US4204989A (da)
EP (1) EP0012686B1 (da)
JP (2) JPS5583714A (da)
AT (1) ATE2048T1 (da)
CA (1) CA1129768A (da)
DE (1) DE2964390D1 (da)
DK (1) DK528279A (da)
IE (1) IE48665B1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
US4349539A (en) * 1980-08-15 1982-09-14 Merck & Co., Inc. Separation of hepatitis B surface antigen
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド B型肝炎ワクチン製造方法
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
CA1232849A (en) * 1983-12-01 1988-02-16 The Washington University Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
US5101018A (en) * 1989-06-12 1992-03-31 International Minerals & Chemical Corp. Method for recovering recombinant proteins
US5047511A (en) * 1989-08-28 1991-09-10 Pitman-Moore, Inc. Method for recovering recombinant proteins
JPH0660773U (ja) * 1993-01-25 1994-08-23 株式会社中川水力 電動サ−ボモ−タ方式電気調速機

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3887697A (en) * 1971-08-09 1975-06-03 Us Health Hemagglutination method for australia antigen and antibody thereto
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
US3992517A (en) * 1975-02-19 1976-11-16 Pfizer Inc. Detection of hepatitis B surface antigen by latex agglutination
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
FR2336141A1 (fr) * 1975-12-23 1977-07-22 Trepo Christian Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4118477A (en) * 1977-02-14 1978-10-03 Merck & Co., Inc. Hepatitis B antigen
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen

Also Published As

Publication number Publication date
IE792390L (en) 1980-06-13
CA1129768A (en) 1982-08-17
JPS6361624B2 (da) 1988-11-29
US4204989A (en) 1980-05-27
JPS5583714A (en) 1980-06-24
ATE2048T1 (de) 1983-01-15
EP0012686B1 (en) 1982-12-22
JPS63264499A (ja) 1988-11-01
JPH0240987B2 (da) 1990-09-14
EP0012686A1 (en) 1980-06-25
DE2964390D1 (en) 1983-01-27
IE48665B1 (en) 1985-04-03

Similar Documents

Publication Publication Date Title
DK163840C (da) Fremgangsmaade til bestemmelse af antigener ved hjaelp af to eller flere monoklonale antistoffer og proeveudstyr til brug ved fremgangsmaaden
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
IT8122654A0 (it) Emulsioni siliconiche trasparenti.
IT1150682B (it) Procedimento per la produzione di sostanze prodotte da cellule,particolarmente di anticorpi e simili
DK162056C (da) Anti-tumor, anti-idiotype-antistof til induktion af immunologisk respons
DK99682A (da) Immunoanalysemetoder under anvendelse af monoklonale antistoffer
DK59778A (da) Fremgangsmaade til fremstilling af antigen og antistof
IT7920592A0 (it) Determinazione di antigeni oppure di anticorpi.
DK158246C (da) Sandwichfremgangsmaade til bestemmelse af carcinoembryonalt antigen og oploesning til brug ved denne fremgangsmaade
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
IT8222140A0 (it) Procedimento senza centrifugazione per prova immunologica dimateriali.
DE3177290T2 (de) Monoklonale antikoerper gegen hepatitis-b-virus.
DK337479A (da) Fremgangsmaade til at modificere de antigeniske egenskaber hoset quercitindel-holdigt graespollen-antigen eller fragment deraf
DK528279A (da) Fremgangsmaade til isolering af hepatitis b e antigen eller antistof
IT7921044A0 (it) Dispositivo per la precisa condotta di volo e navigazione d'aereoplani.
IT7968342A0 (it) Sostanza anti tumorale e procedimento per la sua preparazione
SE8100614L (sv) Humant relaxin och sett for framstellning derav
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
DK152479A (da) Faste blandinger indeholdende alkalimetalakylarylsulfonater samt femgangsmaade til fremstilling af saadanne blandinger og detergenter indeholdende saadanne blandinger
IT8020124A0 (it) Procedimento per la separazione di orto-cloronitrobenzene.
IT7909404A0 (it) Trialcossisilani di fenossialchi le e metodo per la preparazione degli stessi
NL7804208A (nl) Scheidings- analysewerkwijze.
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
IT8026345A0 (it) Procedimento e perfezionamento per la preparazione di dicumilperossido.
IT8125583A0 (it) Procedimento per l'estrazione di brodi di fermentazione nonfiltrati.

Legal Events

Date Code Title Description
ATS Application withdrawn